State of New Mexico House of Representatives FORTY-THIRD LEGISLATURE FIRST SESSION, 1997 March 17, 1997 Mr. Speaker: Your CONSUMER AND PUBLIC AFFAIRS COMMITTEE, to whom has been referred SENATE BILL 272, as amended has had it under consideration and reports same with recommendation that it DO PASS, amended as follows: 1. On page 11, lines 21 and 22, remove the beginning bracket and line-through. 2. On page 11, line 23, remove the line-through and end bracket and strike the underscored "C.". 3. Strike Senate Public Affairs Committee Amendment 2. 4. On page 13, line 7, after the bracket strike the remainder of the line, strike line 8 through "including" and insert in lieu thereof a comma. 5. On page 13, line 9, after the semicolon strike "and". 6. On page 13, strike lines 11 through 17 and insert in lieu thereof: "devices, restricted devices and prescription devices, as those devices are defined in the New Mexico Drug, Device and Cosmetic Act, if the board determines by rule that such devices are necessary in the practice of oriental medicine and if the prescribing doctor of oriental medicine has fulfilled requirements for prescriptive authority in accordance with rules promulgated by the board for the devices enumerated in this paragraph; (4) the prescription or administration of cosmetics, therapeutic serum and over-the-counter drugs, other than those enumerated in Paragraph (2) of this subsection, as those are defined in the New Mexico Drug, Device and Cosmetic Act, if the prescribing doctor of oriental medicine has fulfilled the requirements for prescriptive authority in accordance with rules promulgated by the board for the substances enumerated in this paragraph; and (5) the prescription or administration of the following dangerous drugs as they are defined in the New Mexico Drug, Device and Cosmetic Act, if the prescribing doctor of oriental medicine has fulfilled the requirements for prescriptive authority in accordance with rules promulgated by the board for the substances enumerated in this paragraph: (a) vapocoolants; (b) topical application of naturally occurring hormones; and (c) any of the drugs or substances enumerated in Paragraphs (2) and (4) of this subsection if at any time these substances or drugs are classified as dangerous drugs."". 7. On pages 24 through 26, strike Sections 10 and 11 in their entirety. 8. Renumber the succeeding section accordingly., and thence referred to the APPROPRIATIONS AND FINANCE COMMITTEE. Respectfully submitted, Gary King, Chairman Adopted Not Adopted (Chief Clerk) (Chief Clerk) Date The roll call vote was 5 For 2 Against Yes: 5 No: Crook, Dana Excused: Johnson, Rios, Vigil Absent: None 118863.1 118938.2 G:\BILLTEXT\AMEND_97\S0272CP1